Search for: "Rachel Sachs" Results 21 - 40 of 155
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2020, 11:45 am by Jason Rantanen
Sachs on Reimbursement Policy and Innovation Incentives for COVID-19 July 23: Lisa Larrimore Ouellette on Innovation Policy Pluralism and COVID-19. [read post]
1 May 2022, 6:00 pm by Juvan Bonni
Rachel Sachs: The Accidental Innovation Policymakers (Source: SSRN) Prof. [read post]
6 Dec 2019, 4:07 am by SHG
For the employees of Goldman Sachs, there is now a rule as well. [read post]
14 May 2018, 8:56 am by Neil Schoenherr
Sachs“The administration’s blueprint contains dozens of proposals and over a hundred potential questions to explore in the future,” said Rachel Sachs, associate professor of law in the School of Law, who has written extensively on drug policy and pricing. [read post]
4 Oct 2018, 12:18 pm by Neil Schoenherr
Sachs“In the U.S., we give innovator pharmaceutical companies some period of exclusivity after their product comes to market, before which a biosimilar drug can be approved on the strength of the innovator drugs application in the first instance,” said Rachel Sachs, associate professor of law in the School of Law and an expert on drug policy and pricing. [read post]
29 Apr 2022, 2:00 am by mes286
  University of Virginia School of Law –Stephen Sachs, Antonin Scalia Professor of Law, Harvard Law School, presents today as part of the Faculty Workshop Series. [read post]
31 Aug 2016, 7:02 am by Neil Schoenherr
Sachs“We should not think of ‘price controls’ as a four-letter word,” said Rachel Sachs, associate professor of law and an expert on drug regulation and health law. [read post]
30 Nov 2016, 1:21 pm by Neil Schoenherr
“One of the most troubling provisions in the previous draft of the bill would’ve created a program for the use of ‘clinical experience’ evidence in drug approvals,” said Rachel Sachs, associate professor of law and an expert on drug regulation and health law. [read post]
25 Oct 2018, 9:30 pm by Benjamin Barsky
But the latest health care legislation introduced in Congress and the federal government’s larger policy plan are unlikely to drive the innovations necessary to improve the health of the American people, argues Rachel Sachs, a professor at Washington University School of Law. [read post]
9 Oct 2017, 9:09 am by Neil Schoenherr
Sachs“The best-price rule is not as serious a problem as drug manufacturers might perceive it to be,” said Rachel Sachs, associate professor of law and co-author of “Innovative Contracting for Pharmaceuticals and Medicaid’s Best-Price Rule,” recently published in the Journal of Health Politics, Policy and Law. [read post]
9 Jul 2020, 7:00 am by Neil Schoenherr
“It’s not clear that the president can unilaterally withdraw the United States from membership in the WHO,” said Rachel Sachs, associate professor of law and a renowned expert on health policy and drug law. [read post]
3 Aug 2017, 7:30 am by Neil Schoenherr
“One particularly noteworthy dimension of the 21st Century Cures Act was the way in which it originally moved through the House of Representatives,” said Rachel Sachs, associate professor of law. [read post]
19 Jun 2020, 6:45 am by Neil Schoenherr
“The spread of COVID-19 has brought into the public consciousness many of the issues implicated in my research on innovation policy,” said Rachel Sachs, associate professor of law. [read post]
6 Dec 2021, 6:00 am by Neil Schoenherr
Aduhelm, the first new Alzheimer’s drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works, says Rachel Sachs, the Treiman Professor of Law and nationally renowned expert on drug pricing and health policy. [read post]
5 May 2017, 6:00 am by Doug Cornelius
House Panel Approves Plan to Undo Parts of Dodd-Frank Financial Law by Rachel Witkowski The House Financial Services Committee launched a Republican-supported rollback of Obama-era financial regulations, voting 34-26 along party lines Thursday for a plan to undo significant parts of the 2010 Dodd-Frank law. [read post]
1 Oct 2016, 7:07 am by Zachary Burdette
Natan Sachs commented on the accomplishments of the late Shimon Peres. [read post]
11 Jan 2011, 4:29 am by Broc Romanek
There continues to be a number of interesting articles written about it, including: - New York Magazine's "Lloyd Blankfein's Secret Facebook Feed" (this one has a fake Facebook feed that is pure genius) - Bloomberg's "Goldman Sachs Says It May Sell, Hedge Facebook Stake" - DealBook's "S.E.C. [read post]
16 Aug 2017, 7:45 am by Neil Schoenherr
Rachel Sachs, associate professor of law and expert on drug regulation and health law, contributed a chapter on the role that Christian health care sharing ministries play in the health care system. [read post]
16 Jul 2012, 6:13 am by Rachel, Law Clerk
Here are the leading legal headlines from Wise Law on Twitter for Monday, July 16, 2012: Law Commission of Ontario releases Final Report and Framework for the Law as it Affects Older Adults Constitutionality of Canada's anti-spam legislation - Lexology Dragon Dictate, Goldman Sachs and the $580 Million Black Hole German Jews and Muslims blast circumcision ban Supreme Court gives wide interpretation to ‘fair dealing’ in copyright saga RIM's $147.2M lawsuit loss… [read post]